Personalised Care and Support for people with cancer

  • Slides: 6
Download presentation
Personalised Care and Support for people with cancer Evaluation

Personalised Care and Support for people with cancer Evaluation

Evaluation of personalised care and support Baseline - July to September 2018 1%-100% patients

Evaluation of personalised care and support Baseline - July to September 2018 1%-100% patients had a HNA 79%-100% had care plan 0 -100% treatment summary 37% - 100% risk stratified pathway Various health and wellbeing events are being delivered across all trusts for all cancer sites and all are evaluated Breast 21%-100% Prostate 25%-75% Colorectal 1%-75% Gynae 33%-73% Lung 7%-72% Haem 13%-59% Stratified Pathway Breast 100% (7/7) Prostate 50% (3/6) Colorectal 37% (3/8) Patient experience NCPES action plans Listening events HNA feedback Case studies PROMs, Qo. L Staff experience Survey Listening event Anecdotal evidence and feedback Evaluation supported throughout with patient representatives working collaboratively, providing their opinions, sharing decisions and offering advice from the patient perspective

Interim data collection January to March 2019 CSW doing more HNA and contacts HWBE

Interim data collection January to March 2019 CSW doing more HNA and contacts HWBE offered post -diagnosis Adjust, Adapt & Plan well evaluated Reports show evidence of impact for AHP activity Several more elements to the evaluation are underway Staff experience Patient experience Quality of Life SWAG-wide staff survey Listening event Interviews Cost benefit analysis Local survey Interviews In-depth case studies PROMs, PAMs National metrics Semi-structured interviews Interviews with staff and patients Case studies Staff attending level 2 psychological skills training showed significant increase in knowledge and confidence which increased further at one month follow up suggesting the training is positively impacting clinical practice.

HNA by CNS/CSW 100 90 80 70 60 CSW 50 CNS 40 30 20

HNA by CNS/CSW 100 90 80 70 60 CSW 50 CNS 40 30 20 10 0 NBT baseline NBT Interim WAHT baseline WHAT interim MPH baseline MPH interim YDH basleline YDH interim RUH baseline RUH interim SFT baseline SFT interim

HNA -stage in the pathway 200 180 160 140 NBT 120 WAHT MPH 100

HNA -stage in the pathway 200 180 160 140 NBT 120 WAHT MPH 100 YDH 80 RUH SFT 60 GH 40 20 0 Baseline - around Interim - around Baseline - start or Interim - start or Baseline - end of Interim - end of Baseline - other diagnosis during treatment primary treatment